# Quantitative MRI in Assessing Disease in Patients With Brain Tumors

> **NCT02269111** · NA · TERMINATED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 10 (actual)

## Conditions studied

- Tumors Metastatic to Brain
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **PROCEDURE:** diffusion-weighted magnetic resonance imaging
- **PROCEDURE:** chemical exchange saturation transfer magnetic resonance imaging
- **PROCEDURE:** dynamic contrast-enhanced magnetic resonance imaging
- **PROCEDURE:** dynamic susceptibility contrast-enhanced magnetic resonance imaging

## Key facts

- **NCT ID:** NCT02269111
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04
- **Primary completion:** 2017-10
- **Final completion:** 2018-05
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Change in PI and funding
- **Last updated:** 2018-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02269111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02269111, "Quantitative MRI in Assessing Disease in Patients With Brain Tumors". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02269111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*